These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 22831478)

  • 21. Anti-doping analyses at the Sochi Olympic and Paralympic Games 2014.
    Sobolevsky T; Krotov G; Dikunets M; Nikitina M; Mochalova E; Rodchenkov G
    Drug Test Anal; 2014; 6(11-12):1087-101. PubMed ID: 25312500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Science and the rules governing anti-doping violations.
    Bowers LD
    Handb Exp Pharmacol; 2010; (195):513-31. PubMed ID: 20020378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New and old challenges of sports drug testing.
    Botrè F
    J Mass Spectrom; 2008 Jul; 43(7):903-7. PubMed ID: 18570180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of GH abuse in sport: Past, present and future.
    Barroso O; Schamasch P; Rabin O
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug testing at the 10th Asian Games and 24th Seoul Olympic Games.
    Park J; Park S; Lho D; Choo HP; Chung B; Yoon C; Min H; Choi MJ
    J Anal Toxicol; 1990; 14(2):66-72. PubMed ID: 2325381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of doping: possibilities and limitations].
    Kamber M
    Schweiz Z Sportmed; 1990 Dec; 38(4):197-204. PubMed ID: 2274769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
    Corrigan B; Kazlauskas R
    Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The toxic torch of the modern Olympic Games.
    Prendergast HM; Bannen T; Erickson TB; Honore KR
    Vet Hum Toxicol; 2003 Mar; 45(2):97-102. PubMed ID: 12678299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Accreditation of clinical laboratories based on ISO standards].
    Kawai T
    Rinsho Byori; 2004 Nov; 52(11):900-5. PubMed ID: 15658469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges in Modern Anti-Doping Analytical Science.
    Ayotte C; Miller J; Thevis M
    Med Sport Sci; 2017; 62():68-76. PubMed ID: 28571012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical challenges in the detection of peptide hormones for anti-doping purposes.
    Barroso O; Handelsman DJ; Strasburger C; Thevis M
    Bioanalysis; 2012 Jul; 4(13):1577-90. PubMed ID: 22831474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games.
    Stuart M; Kwon YI; Rhie SJ
    Br J Sports Med; 2019 Sep; 53(17):1105-1110. PubMed ID: 30894336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. World anti-doping regulations for 2005: essential changes for athletes and physicians.
    Pabinger C; Gruber G
    Arch Orthop Trauma Surg; 2006 May; 126(4):286-8. PubMed ID: 16333634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ISO 15189 accreditation: Requirements for quality and competence of medical laboratories, experience of a laboratory I.
    Guzel O; Guner EI
    Clin Biochem; 2009 Mar; 42(4-5):274-8. PubMed ID: 19863920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel antidoping and medical care delivery model at the 2nd Summer Youth Olympic Games (2014), Nanjing China.
    Mountjoy M; Akef N; Budgett R; Greinig S; Li G; Manikavasagam J; Soligard T; Haiming X; Yang X
    Br J Sports Med; 2015 Jul; 49(13):887-92. PubMed ID: 25833900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antidoping control. From a positive result to the consequences].
    dos Reys LL
    Acta Med Port; 1994 May; 7(5):291-5. PubMed ID: 8073904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene doping.
    Haisma HJ; de Hon O
    Int J Sports Med; 2006 Apr; 27(4):257-66. PubMed ID: 16572366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rogue athletes and recombinant DNA technology: challenges for doping control.
    Azzazy HM; Mansour MM
    Analyst; 2007 Oct; 132(10):951-7. PubMed ID: 17893796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008].
    Thevis M; Hemmersbach P; Geyer H; Schänzer W
    Med Klin (Munich); 2009 Dec; 104(12):918-24. PubMed ID: 20039158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.